Holen Sie sich die Stockscreener-App
6.82
0.87%
-0.06
Handel nachbörslich:
6.60
-0.22
-3.23%
Schlusskurs vom Vortag:
$6.88
Offen:
$6.73
24-Stunden-Volumen:
3,120
Relative Volume:
0.34
Marktkapitalisierung:
$94.71M
Einnahmen:
$57.94M
Nettoeinkommen (Verlust:
$-2.34M
KGV:
-40.94
EPS:
-0.1666
Netto-Cashflow:
$3.82M
1W Leistung:
+19.23%
1M Leistung:
+10.00%
6M Leistung:
+7.91%
1J Leistung:
-15.28%
1-Tages-Spanne:
$6.51
$6.82
1-Wochen-Bereich:
$5.71
$7.00
52-Wochen-Spanne:
$5.50
$9.6299
Champions Oncology Inc Stock (CSBR) Company Profile
Firmenname
Champions Oncology Inc
Sektor
Branche
Telefon
410-369-0365
Adresse
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.82 | 88.04M | 57.94M | -2.34M | 3.82M | -0.1666 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-12 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-11-18 | Eingeleitet | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten
Hong Kong IPO Boom Faces Performance Challenges as Post-Listing Returns FadeEarnings Weakness Phase - newsline.com
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation? (LLY:NYSE) - Seeking Alpha
(CSBR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Check For Cancer Champion Dr. Ryan Schoenfeld Has a Vision For Earlier Detection - ACCESS Newswire
Check for Cancer Champion Dr. Ryan Schoenfeld has a vision for earlier detection - Aflac Newsroom
Vail Resorts (MTN) Edges Higher as Ski Season Momentum BuildsModified Schiff - newsline.com
AQU PE Ratio & Valuation, Is AQU Overvalued - Intellectia AI
CSBR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock Edges HigherBook Value Growth - newsline.com
CSBR Q1 2026 Earnings: Earnings Miss Hides Underlying Progress in Oncology PlatformCFO Commentary Report - newsline.com
Champions Oncology Q1 2026 Earnings: EPS Miss of 121.79% Weighs on Results Despite Modest Stock Gain - newsline.com
CGI Inc. (GIB) Faces Pressure: Stock Drops Nearly 4% as Support Levels ApproachPre-Earnings Momentum - newsline.com
CSBR Technical Analysis & Stock Price Forecast - Intellectia AI
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer - Yahoo Finance UK
FedEx Invests $54 Million in Netherlands Truck Hub to Support Air Freight IntegrationProfit Guidance Range - newsline.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
(CSBR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy - marketscreener.com
Champions Oncology Inc. (CSBR) Q1 2026 Earnings: Earnings Miss Estimates as EPS Falls to -$0.02Special Dividend Alert - The Legal Advocate
Apple’s AI Roadmap Faces Pivotal Test at Upcoming WWDCRevenue Recognition Risk - The Legal Advocate
Explore US Stocks on MEXC: Your Gateway to Global Markets | MEXC - MEXC
Champions Oncology Inc. (CSBR) Q1 2026 Earnings: EPS Falls Sharply Below Estimates Amid Challenging QuarterDividend Increase Stocks - The Legal Advocate
Aurora Innovation, Inc. Files Form 8-K with NASDAQ Listing and Company Details – May 2026 - Minichart
Stronger starts with knowing: HCCH champions a new standard of cancer care - BusinessMirror
EQT Q1 2026 Earnings: Earnings Beat Surprise Amidst Energy Market VolatilityEstimate Revision Count - newsline.com
Champions Oncology (CSBR) Gains 1.59% as Stock Approaches Key Resistance LevelVolume Nodes - The Legal Advocate
Sixth Street Specialty Lending (TSLX) Retreats from Recent Highs: Key Levels to WatchCash Flow Strong Stocks - The Legal Advocate
Japan Stocks Surge to All-Time High on Iran Deal OptimismRevenue Surprise History - The Legal Advocate
Champions Oncology (CSBR) Q1 2026 Earnings: EPS Misses by Wide Margin as Company Posts LossTrading Community Hub - Newser
Champions Oncology, Inc.Common Stock (NQ: CSBR - The Chronicle-Journal
KLIC Q1 2026 Earnings: EPS Surges Past Estimates, Stock AdvancesEarnings Miss Streak - The Legal Advocate
Airbnb (ABNB) Reports Weak Q1 2026 — Cost Pressures Weigh on MarginsRevenue Inflection Point - The Legal Advocate
In Vivo CRO Market Size is Poised to be Valued at USD 11.83 - GlobeNewswire
Intel CEO Lip-Bu Tan Signals Foundry Business Gains Traction Amid Growing Customer InterestROA Comparison - The Legal Advocate
Champions Onc (CSBR) Declines -1.48% Amid Market Weakness 2026-05-19Community Breakout Alerts - Newser
(CSBR) Risk Channels and Responsive Allocation - Stock Traders Daily
Champions Onc (CSBR) Q1 2026 Earnings Miss: EPS $-0.02 vs $0.09 ExpectedSocial Signal Watchlist - Newser
Champions Onc (CSBR) Q1 2026 Results Fall Short — EPS $-0.02, Revenue $N/AShort Squeeze - newser.com
Heartland Express, Inc. 8-K SEC Filing Details for May 14, 2026 – Company Information, Stock, and Compliance - Minichart
Qumulo Champions Olivia Newton-John Cancer Research Institute in New “Imagine” Fundraising Campaign - Business Wire
Cizzle Bio CEO Bill Behnke Participates in National Oncology Commercialization Panel at City of Hope's 25th Ci4CC Summit - PR Newswire
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
(CSBR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
How Palmer (PSBD) balances growth with profitability (Mini Rally) 2026-05-07Earnings Miss Risk - The Legal Advocate
Leading Companies Enhancing Their Presence in the Tumor Models Market - openPR.com
Patient-Derived Xenograft (PDX) Models Market (2026-2033) | - openPR.com
Champions Oncology (NASDAQ:CSBR) Shares Cross Below 200-Day Moving AverageWhat's Next? - MarketBeat
Celebration of Champions event held for children affected by cancer - fox5sandiego.com
Liquidity Mapping Around (CSBR) Price Events - Stock Traders Daily
Champions Onc (CSBR) Stock: Is It Forming a Pattern (Market Focus) 2026-04-27MESA MA - newsline.com
Champions Oncology (CSBR) Proxy Filing Summary - Quartr
Champions Oncology (NASDAQ:CSBR) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Finanzdaten der Champions Oncology Inc-Aktie (CSBR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.60%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):